Oliveira, Natália
https://orcid.org/0009-0006-1941-0925
Mayo Clinic
Incyte International Biosciences Sàrl
Citations 2
Pemigatinib For Previously Treated Central Nervous System Tumors With Activating FGFR Mutations or Translocations: Results From FIGHT-207 (S17.004)
Spanggaard, Iben , Matrana, Marc , Rocha‐Lima, Caio, Hervieu, Alice , Ahn, Myung‐Ju , Ahnert, Jordi Rodon, Véronèse, L., Oliveira, Natália , Schäffer, Michael, Mahipal, Amit , Vieito, María , Hervieu, Alice, Goyal, Lipika , Ahnert, Jordi Rodon, Li, Xin , Schaffer, Michael, Kesari, Santosh
Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available
Phase 3 study of oral lenalidomide as maintenance therapy for patients with B-cell chronic lymphocytic leukemia (CLL).
Chanan‐Khan, Asher , Zaritskey, Andrey , Egyed, Miklós , Samoylova, Olga, Simpson, David , Mei, Jay , Oliveira, Natália , Kong, O, Foà, Robin , Vokurka, Samuel , Schuh, Anna
Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS7125-TPS7125